Repligen Corporation (NASDAQ:RGEN) Q2 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Repligen Corporation's Second Quarter of 2024 Earnings Conference Call. [Operator Instructions].
Repligen Corp (RGEN)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Should You Consider Investing in Repligen Corporation (RGEN)?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” second-quarter 2024 investor letter. A copy of the same can be downloaded here.
20 Most Profitable Stocks of the Last 20 Years
The stock market has a long history of generating wealth for investors. While past performance doesn't guarantee future results, studying successful companies can provide valuable insights.
Here’s Why Baron Discovery Fund Sold Repligen Corporation (RGEN)
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
Repligen Corporation misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.29.
Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript
Repligen Corporation reports earnings inline with expectations. Reported EPS is $0.33 EPS, expectations were $0.33.
Here’s Why Repligen Corporation (RGEN) Rose 13% in Q3
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Does Repligen Corp. (RGEN) Have a Bright Future?
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
